News
BOSTON, April 02, 2025--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback